News from the healthcare data industry
The leading open Clinical AI platform allows users to develop and deploy their own AI algorithms and leverage third-party AI algorithms within existing clinical workflows. CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ — ConcertAI’s...
Integrated Measurement Delivers Actionable, Privacy-Safe Patient Insights for Real-Time Planning, Activation, and Optimization NEW YORK, Feb. 27, 2023 /PRNewswire/ — PulsePoint, a technology company revolutionizing health decision-making in real time, today announced...
The leading open Clinical AI platform allows users to develop and deploy their own AI algorithms and leverage third-party AI algorithms within existing clinical workflows. CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ — ConcertAI’s...
The Industry’s leading AI SaaS solution for Acute Cardiac Care bringing critical patient insights to patients’ care teams faster. CAMBRIDGE, Mass., Feb. 24, 2023 /PRNewswire/ — ConcertAI’s TeraRecon Eureka Clinical AI SaaS...
STOCKHOLM, Feb. 23, 2023 /PRNewswire/ — Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc for the treatment...
MINNEAPOLIS, Feb. 22, 2023 /PRNewswire/ — Delve Health and UW Medicine are announcing a collaboration to provide new insights into endemic Type 2 Diabetes research, through artificial intelligence and machine learning (i.e.,...
Collaboration will leverage global patient registries to deliver real-world evidence across rare neuromuscular diseases to biopharmaceutical companies NEW YORK and NEWCASTLE, England, Feb. 22, 2023 /PRNewswire/ — TREAT-NMD Services Ltd, the business arm of...
Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory,...
February 16, 2023 06:29 AM Eastern Standard Time TAMPA, Fla. & TYSONS, Va.–(BUSINESS WIRE)–M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, and Zephyr AI, Inc. (“Zephyr...
Komodo’s technology and clinical insights are helping support patients across more than 20 conditions spanning oncology, chronic illness, and rare disease February 14, 2023 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS...